Early-stage Research Funding from the ZOLL Foundation supports early-career investigators researching serious cardiopulmonary and respiratory conditions to improve patient care.
Product development projects are explicitly ineligible; the Foundation clarified that the 10-year post-degree guideline is flexible and more than 10 publications generally falls outside early-career status, depending on authorship and publication type. Human/animal studies must report ethics-approval status and pending timelines; prospective treatment-comparison trials need safety-monitoring plans; other details changed.
Funder: ZOLL Foundation
Due Dates: March 31, 2027 (Spring) | September 30, 2027 (Fall)
Funding Amounts: Seed grants have ranged from $25,000 to more than $100,000 over two years
Summary: Supports early-career investigators researching ways to improve care for patients with serious cardiopulmonary and respiratory conditions.
Key Information: Applicants need an institutional or agency affiliation and an established investigator providing a reference and ongoing mentorship.
The ZOLL Foundation provides seed funding to early-career investigators worldwide whose research aims to improve care for patients with serious cardiopulmonary and respiratory conditions. Supported fields include emergency medicine, critical care, trauma, cardiovascular and pulmonary health, sleep-disordered breathing, neuroscience, and translational research applying discoveries to training and clinical practice.
The program favors research into new therapies or techniques, better understanding of training and treatment practices, and projects whose initial results could help investigators secure larger awards elsewhere. Proposal quality and mentorship are central to review. Pilot data may support an application but are not required. The program supports research rather than product development.